Midazolam
- Product NDC
- 70860-600
- 11-digit product format
- 708600600
- Labeler code
- 70860
- Product ID
- 70860-600_7127df3c-7f15-4623-95aa-adf0173620ac
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- midazolam hydrochloride
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA090696
- Marketing category
- ANDA
- Marketing start
- 2016-12-14
- Marketing end
- 0000-00-00
- Substance
- MIDAZOLAM HYDROCHLORIDE
- Active strength
- 2 mg/2mL
- Pharmacologic classes
- Benzodiazepine [EPC],Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70860-600 | MIDAZOLAM (MIDAZOLAM HYDROCHLORIDE) INJECTION, SOLUTION [ATHENEX PHARMACEUTICAL DIVISION, LLC.] | 9 | Legacy NDC | 20240306_401a66d1-9374-40af-acd2-73e573584da2.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-600-02 | 70860060002 | 25 VIAL, SINGLE-DOSE in 1 CARTON (70860-600-02) > 2 mL in 1 VIAL, SINGLE-DOSE (70860-600-41) | 2016-12-14 | 0000-00-00 | No | No | Current |